{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Owens & Minor, Inc.
Owens & Minor, Inc. Hits New 52-Week Low at $4.35
Owens & Minor, Inc. has hit a new 52-week low, reflecting a challenging year with a significant stock price decline. Financial metrics show a low P/E ratio and concerning indicators such as negative Return on Equity and a high Debt to Equity ratio, highlighting ongoing valuation and profitability issues.
Is Owens & Minor, Inc. technically bullish or bearish?
As of August 5, 2025, Owens & Minor, Inc. is in a bearish trend, indicated by negative MACD readings, moving averages, and KST, with a year-to-date return of -57.54% compared to the S&P 500's 12.22%.
Is Owens & Minor, Inc. overvalued or undervalued?
As of May 5, 2023, Owens & Minor, Inc. is considered overvalued with a valuation grade of risky, reflected by its low growth metrics and significant underperformance of -57.54% year-to-date compared to the S&P 500's 12.22% return.
Is Owens & Minor, Inc. technically bullish or bearish?
As of June 3, 2025, Owens & Minor, Inc. shows a mildly bearish trend, with mixed signals from key indicators like MACD, moving averages, and Bollinger Bands.
Is Owens & Minor, Inc. overvalued or undervalued?
As of May 5, 2023, Owens & Minor, Inc. is considered overvalued and risky, with a low P/E ratio of 6, an EV to EBITDA ratio of 4.76, and a significant decline of 57.10% in stock performance over the past year compared to the S&P 500's 10.26% gain.
Who are in the management team of Owens & Minor, Inc.?
As of March 2022, the management team of Owens & Minor, Inc. includes Independent Chairman Robert Sledd, CEO Edward Pesicka, and several independent directors: Mark Beck, Lt. Gen. Gwendolyn Bingham, Robert Henkel, Mark McGettrick, and Eddie Moore. This team combines executive leadership with independent oversight.
What does Owens & Minor, Inc. do?
Owens & Minor, Inc. is a healthcare solutions company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $2.632 billion and a market cap of $577.67 million. The company reported a net profit loss of $25 million as of March 2025.
How big is Owens & Minor, Inc.?
As of Jun 18, Owens & Minor, Inc. has a market capitalization of 577.67 million and reported net sales of 10,720.25 million with a net profit of -365.78 million over the latest four quarters. Shareholder's funds are 565.23 million, and total assets amount to 4,656.16 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
